Learning Objectives:

1.         To appreciate the relationship between obesity-related metabolic changes and risk for CKD

2.         To be aware of the numerous described pathophysiologic pathways of obsesity-related CVD and CKD

3.         To be aware of newer more specific targeted therapies in improving clinical outcomes in people with

Session date: 
09/12/2024 - 4:00pm to 5:00pm CDT
Location: 
Via Zoom
5841 S. Maryland Ave
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Matthew R. Weir, MD